NCT06618924Active, not recruiting
Digital Modeling of Thoracic CT and Pulmonary Fibrosis
Quantitative Multi-compartment Study by Thoracic CT Scanning in Progressive Pulmonary Fibrosis
Source: ClinicalTrials.gov · Last updated 1 Oct 2024
Brief summary (registry, in English)
Currently, to our knowledge, there is little data on the combination of tools based on a similar concept to understand and evaluate ILDs. It is expected that this portfolio of multi-tool software implemented in radiology departments, applied to routine thoracic TDM, will provide additional qualitative and quantitative information in real time that will be of great help for diagnosis, prognosis prediction, and treatment decision-making in ILDs.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 16 Sept 2024
- Start date
- 1 Jul 2024
- Primary completion date
- 1 Jul 2029
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Diseases
- Idiopathic pulmonary fibrosis
- NCT number
- NCT06618924
What you commit to
- Study type: Observational
- Planned participants: 300
- From 1 Jul 2024 to the primary completion date, 1 Jul 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Patients under 18 years of age.
Other
- Patients under guardianship/curatorship.
- Patients under AME (State Medical Assistance).
Who the study is looking for
- Informed patients who have consented to participate in the research.
- Retrospective data from patients followed for ILDs who underwent two thoracic TDM scans in inspiration and expiration (IE-TDM) at least one year apart, meeting or not meeting the criteria for progressive fibrosis \[presence of two of the following criteria within one year of follow-up: 1/clinical worsening, 2/radiological evidence of disease progression between the two IE-TDM scans, 3/decline in FVC ≥5% or absolute decrease in DLCO (corrected for Hb) \> 10%\].
- 300 records, based on retrospective data, will constitute the initial AVICENNE database (500 records will be selected at Avicenne Hospital APHP so that 300 meet the quality criteria for inspiration/expiration thoracic TDM scans)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hôpital Avicenne APHP Coordinator of this site? Confirm its status | Bobigny | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.